| Literature DB >> 26254309 |
Natsumi Takeyama1, Yoshikazu Yuki2, Daisuke Tokuhara3, Kazuki Oroku4, Mio Mejima5, Shiho Kurokawa5, Masaharu Kuroda6, Toshiaki Kodama4, Shinya Nagai7, Susumu Ueda4, Hiroshi Kiyono8.
Abstract
Enterotoxigenic Escherichia coli (ETEC) causes severe diarrhea in both neonatal and weaned pigs. Because the cholera toxin B subunit (CTB) has a high level of amino acid identity to the ETEC heat-labile toxin (LT) B-subunit (LTB), we selected MucoRice-CTB as a vaccine candidate against ETEC-induced pig diarrhea. When pregnant sows were orally immunized with MucoRice-CTB, increased amounts of antigen-specific IgG and IgA were produced in their sera. CTB-specific IgG was secreted in the colostrum and transferred passively to the sera of suckling piglets. IgA antibodies in the colostrum and milk remained high with a booster dose after farrowing. Additionally, when weaned minipigs were orally immunized with MucoRice-CTB, production of CTB-specific intestinal SIgA, as well as systemic IgG and IgA, was induced. To evaluate the cross-protective effect of MucoRice-CTB against ETEC diarrhea, intestinal loop assay with ETEC was conducted. The fluid volume accumulated in the loops of minipigs immunized with MucoRice-CTB was significantly lower than that in control minipigs, indicating that MucoRice-CTB-induced cross-reactive immunity could protect weaned pigs from diarrhea caused by ETEC. MucoRice-CTB could be a candidate oral vaccine for inducing both passive and active immunity to protect both suckling and weaned piglets from ETEC diarrhea.Entities:
Keywords: Mucosal immunity; Oral vaccine; Pig ETEC; Plant vaccine
Mesh:
Substances:
Year: 2015 PMID: 26254309 DOI: 10.1016/j.vaccine.2015.07.074
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641